Importantly, anti-CD47 mAb treatment did not mimic the effect of CD47-deficiency on NK phenotype, which is in line with anti-CD47 mAb treatment and CD47-deficiency having divergent effects on atherosclerosis. The gene discussed is CD47; the disease is atherosclerosis.